Beranda › Dermatomiositis › Texas › Houston
Uji klinis Dermatomiositis di Houston, TX
5 studi untuk Dermatomiositis mencari peserta di lokasi sekitar Houston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- UT MD Anderson Cancer Center, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Menerima pesertaFase 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Menerima pesertaFase 3
- Nerve & Muscle Center of Texas, Houston
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Menerima pesertaFase 3
- Nerve & Muscle Center of Texas, Houston
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Menerima pesertaFase 1
- Nerve and Muscle Center of Texas, Houston
Uji klinis Dermatomiositis di kota lain
- Durham, NC8 studi
- Washington, DC7 studi
- New York City, NY5 studi
- Pittsburgh, PA5 studi
- Boston, MA5 studi
- Philadelphia, PA4 studi
- Baltimore, MD4 studi
- Miami, FL4 studi
- Cleveland, OH3 studi
- Kansas City, KS3 studi
- Jacksonville, FL3 studi
- Aurora, CO3 studi
Studi lain di Houston
- Kanker Paru Non-Sel Kecil145 studi
- Kanker Payudara126 studi
- Kanker (semua jenis)121 studi
- Kanker Metastatik104 studi
- Kanker Kolorektal102 studi
- Kanker Ovarium89 studi
- Leukemia Mieloid Akut85 studi
- Kanker Paru78 studi
- Kanker Prostat76 studi
- Kanker Endometrium68 studi
- Kanker Pankreas61 studi
- Melanoma59 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.